Symbol="CYCCP"
AssetType="Preferred Stock"
Name="Cyclacel Pharmaceuticals Inc"
Description="Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops drugs for the treatment of cancer and other proliferative diseases. The company is headquartered in Berkeley Heights, New Jersey."
CIK="1130166"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="25955100"
EBITDA="-28529000"
PERatio="None"
PEGRatio="0"
BookValue="0.406"
DividendPerShare="0"
DividendYield="0.0462"
EPS="-2.047"
RevenuePerShareTTM="0.03"
ProfitMargin="0"
OperatingMarginTTM="-76.57"
ReturnOnAssetsTTM="-0.689"
ReturnOnEquityTTM="-1.345"
RevenueTTM="373000"
GrossProfitTTM="-455000"
DilutedEPSTTM="-2.047"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="1.078"
num_52WeekHigh="22.12"
num_52WeekLow="5.87"
num_50DayMovingAverage="14.68"
num_200DayMovingAverage="13.08"
SharesOutstanding="12497400"
DividendDate="2023-08-01"
ExDividendDate="2023-07-20"
symbol="CYCCP"
open="13.65"
high="13.65"
low="13.65"
price="13.65"
volume="102.00"
latest_trading_day="2023-08-25"
previous_close="12.98"
change="0.67"
change_percent="5.1618%"
aroon_positive_momentum_days="43"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="43"
Volume_recent_avg="2336"
Change_recent_avg="-0.01"
Delta_recent_avg="0.87"
Variance_recent_avg="0.44"
Change_ratio_recent_avg="-0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="43"
Aroon_momentum_negative="57"
image_negative_thumbnail_id_1="503"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_negative_thumbnail_id_2="101"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0075.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="684"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0024.jpeg"
image_positive_thumbnail_id_2="609"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0099.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
